New Alzheimer’s Drug Delivers Disappointing Results
FRIDAY, June 17, 2022 (HealthDay News) — An experimental Alzheimer’s drug called crenezumab did not prevent or slow mental decline in patients with a genetic mutation that greatly raises the risk of developing the disease, the results of a decade-long clinical trial show. The mutation seen in the few hundredContinue Reading